1st Quarter - Report

THE HOBBS GROUP, LLC for JOHNSON & JOHNSON

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.

LobbyistCovered position, as disclosed
DAVID HOBBS Assistant to the President for Legislative Affairs

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Medicare/Medicaid MMM

Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.

LobbyistCovered position, as disclosed
DAVID HOBBS Assistant to the President for Legislative Affairs

Contacted: Office of Management & Budget (OMB); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R.2138, The Investment in America Act of 2007; S.41, The Research Competitiveness Act of 2007

LobbyistCovered position, as disclosed
DAVID HOBBS Assistant to the President for Legislative Affairs

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Bills named: H.R. 2138 (110th), S. 41 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.